Optimi Health Corp. OPTHF
0.24 USD 0.00 (+0.00%)
At closeMay 19, 2026, 4:00 PM EDT
0.23 Day range 0.2801
0.10 52-week range 0.2946
- YTD
- +2.98%
- 1 year
- +63.33%
News
newsfilecorp.com Optimi Health Announces Closing of Oversubscribed US$15 Million Public Offering Vancouver, British Columbia--(Newsfile Corp. - May 21, 2026) - Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN0) (the "Company" or "Optimi"), a commercial-stage pharmaceutical company…
globenewswire.com SRx Health Solutions and EMJX Invest in Recent IPO and Commercial-Stage Pharmaceutical Company of Psychedelics, Optimi Health Corp. (OPTH) NORTH PALM BEACH, Fla., May 21, 2026 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE American: SRXH) (the "Company") and EMJ Crypto Technologies ("EMJX"), a digital-asset treasury operating…
newsfilecorp.com Optimi Health Announces Pricing of Oversubscribed US$15 Million Public Offering and Nasdaq Uplisting Common Shares to Trade on the Nasdaq Capital Market Under the Symbol "OPTH" Vancouver, British Columbia--(Newsfile Corp. - May 20, 2026) - Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN)…
newsfilecorp.com Optimi Health Files LIFE Offering Document in Connection with NASDAQ Listing Vancouver, British Columbia--(Newsfile Corp. - April 23, 2026) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) (the "Company" or "Optimi"), a commercial-stage pharmaceutical manufacturer…
newsfilecorp.com Optimi Health Launches Ibogaine Initiative as U.S. Executive Order Signals Pathway for Psychedelic Drug Products The Company's Health Canada-licensed GMP psychedelic manufacturing platform ready to serve emerging demand for ibogaine, a naturally occurring alkaloid under investigation for opioid use disorder,…
newsfilecorp.com Optimi Health Announces Proposed Nasdaq Listing and U.S. Underwritten Public Offering Vancouver, British Columbia--(Newsfile Corp. - March 16, 2026) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) (the "Company" or "Optimi"), a commercial-stage pharmaceutical company…
newsfilecorp.com Optimi Health Reports Early Clinical Rollout of Natural Psilocybin Capsules for Treatment-Resistant Depression in Australia First Patients of 2026 Treated Outside of Sponsor-Led Clinical Trials Under Australia's Regulated Framework Vancouver, British Columbia--(Newsfile Corp. - February 26, 2026) - Optimi Health Corp.…
newsfilecorp.com Optimi Health Completes Psilocybin Export to Australia for Treatment Resistant Depression Naturally-Derived 5 mg Psilocybin Capsules Mark the Company's Second Drug in Market Under Australia's Authorised Prescriber Scheme Vancouver, British Columbia--(Newsfile Corp. - February 19, 2026) -…
feeds.newsfilecorp.com Optimi Health schließt Psilocybin-Export nach Australien zur Behandlung therapieresistenter Depression ab Vancouver, British Columbia--(Newsfile Corp. - Donnerstag, 19. Februar 2026) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" oder
feeds.newsfilecorp.com Optimi Health meldet Beginn der ersten MDMA-gestützten Behandlungen im Jahr 2026 in einem erweiterten Netzwerk australischer Kliniken Vancouver, British Columbia--(Newsfile Corp. - Montag, 16. Februar 2026) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi"
feeds.newsfilecorp.com Optimi Health Completes MDMA Export for PTSD Treatment Under Australia's Authorised Prescriber Scheme Vancouver, British Columbia--(Newsfile Corp. - February 9, 2026) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or
newsfilecorp.com Optimi Health Completes First 2026 Production of MDMA and Psilocybin Capsules Australia's Department of Health has issued import permits for Optimi's MDMA and psilocybin capsules for use under the Authorised Prescriber Scheme Vancouver, British Columbia--(Newsfile Corp. -…
defenseworld.net Optimi Health (OTCMKTS:OPTHF) Trading 5.2% Higher – Still a Buy? Optimi Health Corp. (OTCMKTS:OPTHF - Get Free Report) traded up 5.2% during trading on Wednesday. The stock traded as high as $0.24 and last traded at $0.24. 1,041 shares changed hands during…
newsfilecorp.com Optimi Health Announces Equity Incentive Grants and Corporate Update Vancouver, British Columbia--(Newsfile Corp. - January 16, 2026) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a Canadian GMP-compliant manufacturer of MDMA…
newsfilecorp.com Optimi Health to Present at the Sidoti Micro-Cap Conference on January 21-22, 2026 Vancouver, British Columbia--(Newsfile Corp. - January 14, 2026) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a leading producer of prescribed psychedelic…
defenseworld.net Optimi Health (OTCMKTS:OPTHF) Trading Down 1.4% – What’s Next? Optimi Health Corp. (OTCMKTS:OPTHF - Get Free Report)'s stock price was down 1.4% during mid-day trading on Tuesday. The company traded as low as $0.23 and last traded at $0.2470. Approximately…
feeds.newsfilecorp.com Optimi Health Announces Appointment of New Director Vancouver, British Columbia--(Newsfile Corp. - December 18, 2025) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or
newsfilecorp.com Optimi Health to Supply MDMA to MAPS Israel's Clinical Trial for Trauma-Related PTSD Approved multicenter study sponsored by Sheba Medical Center to compare group and individual MDMA-assisted therapy for 168 patients experiencing trauma-related PTSD Vancouver, British…
newsfilecorp.com Optimi Health's Psilocybin Capsules Selected for Medibank Insurance Program Australia's largest private health insurer expands its AUD $10M psychotherapy program to cover psilocybin for Treatment-Resistant Depression, building on earlier MDMA coverage for PTSD Vancouver,…